The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation.

BACKGROUND: There is no single definitive test to identify prostate cancer in men. Biopsies are commonly used to obtain samples of prostate tissue for histopathological examination. However, this approach frequently misses cases of cancer, meaning that repeat biopsies may be necessary to obtain a di...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Health Technol Assess
Autors principals: Nicholson, Amanda, Mahon, James, Boland, Angela, Beale, Sophie, Dwan, Kerry, Fleeman, Nigel, Hockenhull, Juliet, Dundar, Yenal
Format: Artigo
Idioma:Inglês
Publicat: NIHR Journals Library 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780983/
https://ncbi.nlm.nih.gov/pubmed/26507078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta19870
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars